Furthermore, our results showed that the RNA levels determined by EdgeSeq PIP aligned well with the protein levels determined by the IHC assessment of two important immunotherapy biomarkers, the fraction of PD-L1-positive tumor cells and CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.